Compare M&A Research Institute Holdings, Inc. with Similar Stocks
Dashboard
1
The company declared positive results in Mar'26 after negative results in Dec'25
- OPERATING CASH FLOW(Y) Highest at JPY 3,399.89 MM
- RAW MATERIAL COST(Y) Fallen by -4.38% (YoY)
- NET SALES(Q) Highest at JPY 5,624.83 MM
2
With ROE of 47.86%, it has a fair valuation with a 8.42 Price to Book Value
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Capital Markets
JPY 47,501 Million (Small Cap)
18.00
NA
0.00%
-999,999.00
47.86%
7.02
Revenue and Profits:
Net Sales:
5,625 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,217 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.77%
0%
50.77%
6 Months
-8.35%
0%
-8.35%
1 Year
-28.21%
0%
-28.21%
2 Years
-61.08%
0%
-61.08%
3 Years
-70.17%
0%
-70.17%
4 Years
-72.71%
0%
-72.71%
5 Years
0%
0%
0.0%
M&A Research Institute Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
470.99%
EBIT Growth (5y)
302.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
40.80%
Dividend Payout Ratio
10.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
100.20%
ROE (avg)
45.27%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
8.42
EV to EBIT
10.11
EV to EBITDA
9.40
EV to Capital Employed
10.13
EV to Sales
2.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
100.20%
ROE (Latest)
47.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
5,624.80
3,480.60
61.60%
Operating Profit (PBDIT) excl Other Income
2,114.20
838.60
152.11%
Interest
19.90
3.20
521.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,216.70
419.80
189.83%
Operating Profit Margin (Excl OI)
334.10%
207.70%
12.64%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 61.60% vs -4.01% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 189.83% vs -57.93% in Mar 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
16,602.60
16,549.60
0.32%
Operating Profit (PBDIT) excl Other Income
5,318.10
8,466.00
-37.18%
Interest
21.30
1.20
1,675.00%
Exceptional Items
-21.10
-6.90
-205.80%
Consolidate Net Profit
2,747.30
5,788.60
-52.54%
Operating Profit Margin (Excl OI)
289.30%
508.10%
-21.88%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 0.32% vs 91.49% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is -52.54% vs 118.69% in Sep 2024
About M&A Research Institute Holdings, Inc. 
M&A Research Institute Holdings, Inc.
Capital Markets
No Details Available.
Company Coordinates 
No Company Details Available






